Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
36 hedge funds and large institutions have $4.77M invested in Ocean Biomedical, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 17 closing their positions.
405% more call options, than puts
Call options by funds: $647K | Put options by funds: $128K
22% less funds holding
Funds holding: 46 → 36 (-10)
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
72% less capital invested
Capital invested by funds: $17.1M → $4.77M (-$12.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$264K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$232K |
| 3 |
Goldman Sachs
New York
|
+$111K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$75.9K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$41.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$929K |
| 2 |
BlackRock
New York
|
-$633K |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$208K |
| 4 |
State Street
Boston,
Massachusetts
|
-$177K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$154K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$22 | -13 | -12% |
|
|
AWM
52
Avior Wealth Management
Omaha,
Nebraska
| – | -$7 | -2 | Closed |
|
|
FIA
53
FNY Investment Advisers
New York
| – | +$341 | +200 | +33% |
|
OCEA Hedge Fund Activity: Q2 2024 in Review
36 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q2 2024, worth a combined $4.77M — down 72% from $17.1M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of OCEA and 7 opened new positions — a net loss of 10 holders — while 15 trimmed existing stakes and 10 added.
The largest buyer was Millennium Management, adding an estimated $264K. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $929K sold.
- 36 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q2 2024, down from 46 in Q1 2024.
- Funds reported $4.77M of Ocean Biomedical, Inc. Common Stock stock for Q2 2024, down 72% quarter-over-quarter.
- 7 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q2 2024 and 17 closed out, a net change of -10 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q2 2024 was Millennium Management, an estimated $264K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q2 2024 was OMERS Administration Corp, an estimated $929K sold.
Based on aggregated 13F filings for Q2 2024.